• 1
    Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision. Washington, DC: American Psychiatric Association; 2000.
  • 2
    DiMartini A, Day N, Dew MA, Javed L, Fitzgerald MG, Jain A, et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 2006; 12: 813-820.
  • 3
    Saunders JB, Aasland OG, Babor TF, De la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993; 88: 791-804.
  • 4
    Reeves RR, Pendarvis EJ, Kimble R. Unrecognized medical emergencies admitted to psychiatric units. Amer J Emerg Med 2000; 18: 390-393.
  • 5
    European Association for the Study of the Liver. EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease. J Hepatol 2012; 57: 399-420.
  • 6
    Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989; 84: 1353-1357.
  • 7
    Sarff M, Gold J. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med 2010; 38( 9 suppl): S494-S501.
  • 8
    Lucey MR, Connor JT, Boyer TD, Henderson JM, Rikkers LF; for DIVERT Study Group. Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function. Am J Gastroenterol 2008; 103: 1698-1706.
    Direct Link:
  • 9
    Miller WR, Rollnick S. Motivational Interviewing, 2nd ed.: Preparing People for Change. New York: Guilford Press; 2002.
  • 10
    Whitlock EP, Polen MR, Green CA, Orleans T, Klein J, U.S. Preventive Services Task Force. Clinical guidelines: behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140: 557-580.
  • 11
    Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, et al. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry 2010; 167: 668-675.
  • 12
    Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The Alcohol Use Disorders Identification Test: Guidelines for use in primary care. Second edition. Geneva, Switzerland: World Health Organization Department of Mental Health and Substance Dependence; 2001.